Centre Asset Management Boosted Applied Materials (AMAT) Stake; Last Week Intercept Pharmaceuticals, Inc. (ICPT) Coverage

Centre Asset Management Llc increased Applied Materials Inc (AMAT) stake by 20% reported in 2017Q3 SEC filing. Centre Asset Management Llc acquired 26,800 shares as Applied Materials Inc (AMAT)’s stock rose 23.58%. The Centre Asset Management Llc holds 160,800 shares with $8.38 million value, up from 134,000 last quarter. Applied Materials Inc now has $62.45 billion valuation. The stock decreased 1.39% or $0.84 during the last trading session, reaching $59.44. About 15.07M shares traded or 6.33% up from the average. Applied Materials, Inc. (NASDAQ:AMAT) has risen 121.40% since March 17, 2017 and is uptrending. It has outperformed by 104.70% the S&P500.

Among 23 analysts covering Intercept Pharmaceuticals (NASDAQ:ICPT), 12 have Buy rating, 3 Sell and 8 Hold. Therefore 52% are positive. Intercept Pharmaceuticals has $423 highest and $45.0 lowest target. $154.49’s average target is 137.79% above currents $64.97 stock price. Intercept Pharmaceuticals had 73 analyst reports since August 10, 2015 according to SRatingsIntel. On Wednesday, November 18 the stock rating was maintained by Oppenheimer with “Outperform”. The stock has “Buy” rating by Wedbush on Monday, February 12. The rating was downgraded by Goldman Sachs on Wednesday, February 7 to “Sell”. On Wednesday, October 28 the stock rating was downgraded by Bank of America to “Underperform”. Needham maintained Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) on Monday, July 31 with “Hold” rating. The firm has “Buy” rating given on Friday, September 22 by Cowen & Co. The stock of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) has “Buy” rating given on Monday, July 31 by Cowen & Co. Credit Suisse maintained Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) rating on Monday, January 22. Credit Suisse has “Buy” rating and $167.0 target. The stock has “Outperform” rating by Wedbush on Monday, August 10. The firm has “Hold” rating given on Friday, September 15 by Needham. See Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) latest ratings:

15/02/2018 Broker: BMO Capital Markets Old Rating: Outperform New Rating: Outperform Old Target: $152 New Target: $155 Maintain
13/02/2018 Broker: Wells Fargo Rating: Hold New Target: $57.0 Maintain
12/02/2018 Broker: Wedbush Rating: Buy New Target: $253.0 Maintain
07/02/2018 Broker: Goldman Sachs Rating: Sell New Target: $45.0 Downgrade
01/02/2018 Broker: Wedbush Rating: Buy New Target: $253.0 Maintain
01/02/2018 Broker: Deutsche Bank Rating: Buy New Target: $106.0
25/01/2018 Broker: Wedbush Rating: Buy New Target: $253.0 Maintain
22/01/2018 Broker: Credit Suisse Rating: Buy New Target: $167.0 Maintain
13/12/2017 Broker: Deutsche Bank Rating: Buy New Target: $106 Initiates Coverage On
16/11/2017 Broker: Wedbush Rating: Buy New Target: $253.0 Maintain

Since October 5, 2017, it had 0 insider purchases, and 5 insider sales for $11.95 million activity. 125,125 shares valued at $6.44M were sold by Salehpour Ali on Friday, December 29. Shares for $1.54M were sold by Larkins Thomas F. Another trade for 53,466 shares valued at $2.83 million was sold by Nalamasu Omkaram. 4,000 shares valued at $214,680 were sold by Forrest Stephen R on Wednesday, January 3. Iannotti Thomas J also sold $922,050 worth of Applied Materials, Inc. (NASDAQ:AMAT) shares.

Investors sentiment decreased to 0.86 in 2017 Q3. Its down 0.20, from 1.06 in 2017Q2. It dropped, as 40 investors sold AMAT shares while 325 reduced holdings. 123 funds opened positions while 263 raised stakes. 811.15 million shares or 1.86% less from 826.54 million shares in 2017Q2 were reported. Paragon Capital Management Limited holds 0.1% in Applied Materials, Inc. (NASDAQ:AMAT) or 5,130 shares. United Services Automobile Association reported 1.68M shares. Products Prtn Limited Liability Com reported 0.3% of its portfolio in Applied Materials, Inc. (NASDAQ:AMAT). 325,775 are held by Avalon Limited Liability Corporation. Glenmede Na reported 2.54 million shares. Scotia Capital invested 0.01% in Applied Materials, Inc. (NASDAQ:AMAT). Ameriprise Financial holds 11.17M shares. James Rech has 40,770 shares for 0.07% of their portfolio. Ardsley Advisory Ptnrs reported 15,000 shares. Amer Century Inc holds 0.71% of its portfolio in Applied Materials, Inc. (NASDAQ:AMAT) for 13.51 million shares. Nikko Asset Management Americas Inc invested 0.07% in Applied Materials, Inc. (NASDAQ:AMAT). New Jersey Better Educational Savings reported 4,000 shares stake. Principal Financial Gru invested in 0.14% or 2.81 million shares. National Bank Of Hawaii holds 0.09% or 21,600 shares in its portfolio. Hbk Investments Lp has invested 0.1% in Applied Materials, Inc. (NASDAQ:AMAT).

Among 28 analysts covering Applied Materials Inc. (NASDAQ:AMAT), 28 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Applied Materials Inc. has $76.0 highest and $12 lowest target. $55.08’s average target is -7.34% below currents $59.44 stock price. Applied Materials Inc. had 117 analyst reports since August 4, 2015 according to SRatingsIntel. B. Riley & Co maintained the shares of AMAT in report on Friday, February 19 with “Neutral” rating. The rating was upgraded by Deutsche Bank on Thursday, February 15 to “Buy”. The stock of Applied Materials, Inc. (NASDAQ:AMAT) earned “Buy” rating by Stifel Nicolaus on Monday, February 13. The rating was upgraded by Needham on Monday, January 8 to “Strong Buy”. Bank of America maintained it with “Buy” rating and $76 target in Wednesday, November 15 report. The stock has “Buy” rating by Credit Agricole on Friday, September 25. The stock of Applied Materials, Inc. (NASDAQ:AMAT) earned “Hold” rating by RBC Capital Markets on Tuesday, August 1. B. Riley & Co maintained Applied Materials, Inc. (NASDAQ:AMAT) rating on Thursday, September 28. B. Riley & Co has “Buy” rating and $63 target. The stock of Applied Materials, Inc. (NASDAQ:AMAT) earned “Positive” rating by Susquehanna on Tuesday, January 16. DA Davidson upgraded it to “Buy” rating and $28 target in Monday, June 27 report.

Investors sentiment decreased to 1.31 in 2017 Q3. Its down 0.02, from 1.33 in 2017Q2. It fall, as 33 investors sold Intercept Pharmaceuticals, Inc. shares while 30 reduced holdings. 30 funds opened positions while 54 raised stakes. 18.23 million shares or 10.01% less from 20.26 million shares in 2017Q2 were reported. Bancorp Of Montreal Can owns 16,470 shares or 0% of their US portfolio. Citadel holds 0% of its portfolio in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) for 28,205 shares. Royal Bank & Trust Of Canada stated it has 90,510 shares. Altrinsic Global Ltd Liability Com holds 232,544 shares. Geode Capital Mngmt Ltd reported 161,605 shares. Pub Employees Retirement Sys Of Ohio holds 0% or 7,144 shares in its portfolio. Northern Tru Corporation reported 0% of its portfolio in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT). Bancshares Of America De stated it has 345,238 shares. 8,500 are owned by Css Il. Oz L P holds 0.05% or 182,700 shares in its portfolio. Deutsche Comml Bank Ag invested in 0.01% or 211,076 shares. Schwab Charles Inv Management reported 48,529 shares. Orbimed Advsrs Ltd Liability owns 386,380 shares. X Mgmt Limited Liability Com holds 0% in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) or 214 shares. 300 are owned by Edge Wealth Mgmt Ltd Limited Liability Company.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter:



 

Recent Posts